Table 2 Patient characteristics in the P2 and P3 protocols
| Â | P2 | P3 | P value* |
|---|---|---|---|
Number of patients | 220 | 220 | Â |
Number of cycles | 220 | 220 | Â |
Age of woman (y) | 38.0 ± 3.7 | 37.8 ± 3.1 |  |
Age of man (y) | 38.4 ± 5.6 | 38.0 ± 6.2 |  |
BMI of woman (kg/m2) | 24.6 ± 2.7 | 24.7 ± 2.8 |  |
Woman with tobacco use (%) | 38.1 | 38.6 | Â |
Day 3 FSH (IU/l) | 9.7 ± 3.0 | 9.6 ± 3.1 |  |
Day 3 LH (IU/l) | 3.9 ± 2.5 | 4.2 ± 2.0 |  |
Mean day 3 estradiol (± SD) (pg/ml) | 70.5 (8.3) | 69.3 (6.4) |  |
Mean day 3 inhibin B (± SD) (IU/l) | 35.5 (5.2) | 40.0 (5.1) |  |
Mean day 3 AMH (± SD) (ng/ml) | 1.2 (0.4) | 1.3 (0.7) |  |
% of patients with a total day 3–5 antral follicles < 6 | 27.2 | 25.9 |  |
Duration of infertility (± SD) in y | 4.6 (2.1) | 4.7 (2.0) |  |
Primary infertility (%) | 68.6 | 66.8 | Â |
Indications (%) | Â | Â | Â |
Tubal | 16.8 | 17.7 | Â |
Male | 45.4 | 42.7 | Â |
Endometriosis stage I or II | 12.2 | 10.0 | Â |
Mixed | 12.2 | 14.0 | Â |
Unexplained | 13.4 | 15.6 | Â |